Stute Joins Citi to Strengthen Healthcare M&A

Jeff Stute, a veteran investment banker with over thirty years of experience at Perella Weinberg Partners and JPMorgan Chase, is set to join Citigroup as a vice chair focused on healthcare mergers and acquisitions in North America. His recruitment is part of Citi's broader strategy to capture a larger market share in the healthcare sector, targeting competition from firms such as Centerview Partners, JPMorgan, and Goldman Sachs. Stute's extensive background includes advising on major pharmaceutical transactions and leading healthcare investment banking efforts, which Citi hopes will enhance its already growing presence in healthcare M&A. The appointment aligns with Citi's recent internal promotions within its healthcare investment banking team, as the sector focuses more on strategic smaller private targets following large-scale acquisitions by major pharmaceutical companies the previous year. Despite a decline in global healthcare M&A deal volumes, Citi has maintained a strong presence in healthcare deals, as evidenced by its advisory role in the $16.5 billion sale of Catalent to the parent company of Novo Nordisk.